Insomnia & Movement Disorders

New Study: Insomnia’s Impact Comes From Unpredictability, Not Sleep Duration
Apps/Artificial Intelligence Insomnia

New Study: Insomnia’s Impact Comes From Unpredictability, Not Sleep Duration

 Sleep.ai announced findings from a peer-reviewed study led by Washington State University, in collaboration with the University of Washington, exploring sleep patterns in people with chronic insomnia. It is the longest known objective, real-world characterization of objective sleep in chronic insomnia. Published in JMIR Formative Research, the study tracked 112 adults […]

Nexalin Announces Peer-Reviewed Publication with Neuroimagina Data in Psychotherapy and Psychosomatics Hiahliahting Brain-Network Effects and Clinical Improvement in Chronic Insomnia
Insomnia Research/Studies

Nexalin Study Shows Brain-Network Changes and Sleep Improvement in Chronic Insomnia

Nexalin Technology, Inc. announced the online publication of a peer-reviewed study in Psychotherapy and Psychosomatics reporting significant clinical improvement and measurable brain-network modulation in patients with chronic insomnia treated with the Company’s high-power 15 mA, 77.5 Hz stimulation approach. The paper was published online on April 20, 2026.  The study, titled: “Modulating […]

Sleep Medicine Physician Dr. Funke Afolabi-Brown Launches Online Insomnia Program, Joins HumanUp as Expert Sleep Partner
Insomnia & Movement Disorders Mental & Behavioral Health Partnerships

Sleep Medicine Physician Dr. Funke Afolabi-Brown Launches Online Insomnia Program, Joins HumanUp as Expert Sleep Partner

Dr. Funke Afolabi-Brown, a board-certified sleep medicine physician and founder of The Restful Sleep Place, is expanding her national reach through a series of initiatives, including a new role as sleep expert for the parenting platform HumanUp, a feature in Sleep Review Magazine, and the launch of a comprehensive online insomnia program […]

Nexalin Announces Pivotal HALO Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market
Industry News Insomnia Research/Studies

Nexalin’s HALO Clarity Trial to Support Planned De Novo FDA Submission Targeting Insomnia Market

Nexalin Technology, Inc. announced continued advancement toward its planned pivotal clinical trial evaluating HALO™ Clarity for the treatment of moderate to severe insomnia, designed to support Nexalin’s planned de novo submission to the U.S. Food and Drug Administration. The study is being conducted in collaboration with Lindus Health, a full-service clinical […]

Noctrix Raises $33.5M Expanding Leadership to Accelerate U.S. Commercialization of Nidra(R) Therapy for Restless Legs Syndrome
Restless Leg Syndrome Product/Vendor Updates

Noctrix Health Raises $33.5M, Expands Leadership Team of Nidra Therapy for Restless Legs Syndrome (RLS)

Noctrix Health, Inc., the developer of the Nidra® Tonic Motor Activation (TOMAC) therapy for Restless Legs Syndrome (RLS), announced a significant expansion of private financing to accelerate its U.S. commercial launch. The company also announced several key leadership appointments to strengthen its commercial and scientific teams. Financing Update Noctrix Health […]

Specific Gut Bacteria Maybe Linked to Insomnia
Insomnia Research/Studies

Specific Gut Bacteria Linked to Insomnia

Specific types of gut bacteria may increase or decrease the risk for insomnia, while insomnia itself may in turn alter the abundance of certain gut bacteria, a new study showed. However, outside experts challenged the investigators’ assertion that the link is causal.  Investigators identified 14 groups of bacteria associated with increased […]